Over 300 studies reviewed
Over 20,000 participants since 1990
Over 140 Investigators
Over 130 Postdoctoral Fellowships
The CTN is a Canada-wide partnership of researchers, people living with HIV and their caregivers, governments, health advocates, and the innovative pharmaceutical and biotechnology industry who are all committed to generating knowledge on the prevention, treatment, and management of HIV, hepatitis C (HCV), and other sexually transmitted and blood-borne infections (STBBIs) and developing a cure for HIV, through the conduct of scientifically sound clinical trials, research, and other interventions. The CTN is dedicated to engaging with community and maximizing the impact of research and ultimately improving the health of Canadians by applying knowledge gained through research at home and abroad into clinical and non-clinical practice.
In 2019-2024, the CTN will continue to facilitate and support high-quality, community-collaborative, investigator-driven clinical trials and innovative non-interventional research, while continuing to translate knowledge available in both official languages, to provide mentorship and training, and to share resources and expertise. The CTN’s strategic priorities for 2019-24 are the following:
1. National and Strategic Research Agenda: To develop, adapt and implement a strategic research agenda aligned with current and emerging priorities in HIV, HCV, STBBIs and other related health conditions;
2. Network Structure, Governance and Management: To sustain a national infrastructure that enables Canadian researchers to conduct innovative research in collaboration with the community;
3. Excellence of the Team: To ensure that the CTN continues to be a high-performance, service-oriented, and accountable organization that supports researchers to deliver and translate high-quality science that has a measurable impact on the health of Canadians and beyond;
4. Network Training and Career Development: To continue to strengthen capacity to conduct patient-oriented, clinical and virological, outcomes-based research through training and mentoring initiatives;
5. Network Impact: To ensure the relevance of our work through the active and meaningful involvement of stakeholders and partners (including people living with HIV, community organizations, clinicians, policymakers, and relevant national networks) in CTN activities and governance committees;
6. Knowledge Translation: To continue to enable the timely translation and uptake of knowledge generated through the Network, into health outcome improvements and guidelines for patient
The 10th International AIDS Society Conference on HIV Science – known as IAS 2019 – will take place on July…
Investment will support research on prevention, treatment, and developing a cure for HIV.
Today, more than half of all people living with HIV in Canada are 50 years or older. This is mostly because people are living much longer, healthier lives with HIV thanks to the success of antiretroviral therapy (ART).
CTN National Director Dr. Aslam Anis commented on new findings from study which found that the risk of transmitting HIV to a sexual partner is completely eliminated in people on ART.